O-(D-glucopyranosylidene)amino-Z-N-Naphthylcarbamate

ID: ALA3786399

Chembl Id: CHEMBL3786399

PubChem CID: 127031893

Max Phase: Preclinical

Molecular Formula: C17H19N3O6

Molecular Weight: 361.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1cccc2ccccc12)O/N=C1\N[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C17H19N3O6/c21-8-12-13(22)14(23)15(24)16(18-12)20-26-17(25)19-11-7-3-5-9-4-1-2-6-10(9)11/h1-7,12-15,21-24H,8H2,(H,18,20)(H,19,25)/t12-,13-,14+,15-/m1/s1

Standard InChI Key:  XUELGMWFLAHUGK-APIJFGDWSA-N

Alternative Forms

  1. Parent:

    ALA3786399

    ---

Associated Targets(Human)

GBA1 Tclin Beta-glucocerebrosidase (14647 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

agl1 Alpha-glucosidase (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
lacZ Beta-galactosidase (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Alpha-galactosidase (362 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.35Molecular Weight (Monoisotopic): 361.1274AlogP: -0.25#Rotatable Bonds: 3
Polar Surface Area: 143.64Molecular Species: NEUTRALHBA: 7HBD: 6
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.95CX Basic pKa: 1.78CX LogP: -0.31CX LogD: -0.31
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.33Np Likeness Score: 0.03

References

1. Wang J, Wang X, Zhao Y, Ma X, Wan Y, Chen Z, Chen H, Gan H, Li J, Li L, Wang PG, Zhao W.  (2016)  Synthesis and biological evaluation ofd-gluconhydroximo-1,5-lactam and its oxime-substituted derivatives as pharmacological chaperones for the treatment of Gaucher disease,  (2): [10.1039/C5MD00501A]

Source